Sigma Healthcare Limited
SIG
Helyezés a részvények között
#1048
Sigma Healthcare Limited, together with its various operating divisions,... Sigma Healthcare Limited, together with its various operating divisions, primarily engages in the wholesale supply and distribution of pharmaceutical goods across Australia. The company also manages a significant network of approximately 1,200 retail pharmacies, encompassing both independent outlets and prominent brands such as Amcal, Discount Drug Stores, Guardian, WholeLife, and PharmaSave. Beyond retail, its comprehensive service portfolio includes wholesale provisions for hospital pharmacies, as well as crucial dose administration aid services delivered to the aged care sector, community pharmacies, and directly to individuals in their homes. Furthermore, Sigma offers advanced technology solutions and data analytics, alongside product development and support for its range of private and exclusive label products. It is also a key supplier of medical consumables and devices to a broad spectrum of customers, from pharmacies and aged care facilities to hospitals and clinics. In addition, the company provides contract logistics services to pharmaceutical manufacturers and other supply partners. Established in 1912, Sigma Healthcare Limited maintains its corporate headquarters in Rowville, Australia.
Részvényárfolyam
$1.94
Piaci kapitalizáció
$22.30B
Változás (1 nap)
-0.57%
Változás (1 év)
-1.74%
Ország
AU
Kereskedés Sigma Healthcare Limited (SIG)
Kategória
Healthcare
Bevétel a(z) Sigma Healthcare Limited (SIG) részvényhez
Bevétel ekkor: Jun 2026 TTM: $7.64B
Sigma Healthcare Limited legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $7.64B. 2024 évben a vállalat $2.18B árbevételt ért el, amely csökkenés a 2023 évben elért $2.58B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Sigma Healthcare Limited bevételtörténete 2001 és 2026 között
Bevétel az év végén
| Év | Bevétel | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $7.64B | 150.36% |
| 2025 | $3.05B | 39.95% |
| 2024 | $2.18B | -15.49% |
| 2023 | $2.58B | 5.96% |
| 2022 | $2.44B | -5.99% |
| 2021 | $2.59B | 19.30% |
| 2020 | $2.17B | -24.90% |
| 2019 | $2.89B | -12.38% |
| 2018 | $3.30B | -0.28% |
| 2017 | $3.31B | 35.12% |
| 2016 | $2.45B | 0.35% |
| 2015 | $2.44B | -6.25% |
| 2014 | $2.60B | -15.90% |
| 2013 | $3.10B | 1.20% |
| 2012 | $3.06B | 4.45% |
| 2011 | $2.93B | 27.32% |
| 2010 | $2.30B | 4.91% |
| 2009 | $2.19B | -18.21% |
| 2008 | $2.68B | 26.67% |
| 2007 | $2.12B | 27.55% |
| 2006 | $1.66B | 531.67% |
| 2004 | $262.65M | 32.71% |
| 2003 | $197.92M | 42.01% |
| 2002 | $139.37M | 98.14% |
| 2001 | $70.34M | 0.00% |
Hasonló cégek vagy versenytársak bevétele
| Vállalat | Bevétel | Bevételkülönbség | Ország |
|---|---|---|---|
| $410.98B | 5,278.14% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,227.10% |
US
|
|
| - | - |
US
|
|
| $13.60B | 78.00% |
US
|
